Citizens Jmp Cuts U.S. Physical Therapy (NYSE:USPH) Price Target to $98.00

U.S. Physical Therapy (NYSE:USPH) had its price target dropped by Citizens Jmp from $113.00 to $98.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage currently has a “market outperform” rating on the stock. Citizens Jmp’s price target would suggest a potential upside of 59.62% from the stock’s current price.

Other equities research analysts also recently issued reports about the stock. Zacks Research downgraded shares of U.S. Physical Therapy from a “hold” rating to a “strong sell” rating in a report on Tuesday, April 28th. Weiss Ratings reissued a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, January 21st. Jefferies Financial Group raised shares of U.S. Physical Therapy to a “strong-buy” rating in a report on Thursday, March 12th. Barrington Research reiterated an “outperform” rating and issued a $103.00 price objective on shares of U.S. Physical Therapy in a research note on Friday, February 20th. Finally, Citigroup restated an “outperform” rating on shares of U.S. Physical Therapy in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, U.S. Physical Therapy currently has a consensus rating of “Moderate Buy” and an average price target of $100.75.

U.S. Physical Therapy Stock Performance

NYSE:USPH traded up $2.40 during trading hours on Friday, reaching $61.40. The stock had a trading volume of 84,058 shares, compared to its average volume of 194,703. The stock has a market cap of $928.48 million, a P/E ratio of 122.79, a price-to-earnings-growth ratio of 1.95 and a beta of 1.21. The stock has a 50 day simple moving average of $76.22 and a 200 day simple moving average of $79.53. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.01. U.S. Physical Therapy has a 12-month low of $58.19 and a 12-month high of $93.50.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.46 EPS for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.09). The firm had revenue of $198.29 million for the quarter, compared to analysts’ expectations of $200.94 million. U.S. Physical Therapy had a net margin of 4.36% and a return on equity of 8.69%. The firm’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period in the prior year, the company earned $0.48 EPS. On average, research analysts forecast that U.S. Physical Therapy will post 2.87 EPS for the current fiscal year.

Insider Buying and Selling at U.S. Physical Therapy

In related news, EVP Richard Binstein sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, March 6th. The shares were sold at an average price of $81.64, for a total value of $244,920.00. Following the sale, the executive vice president directly owned 24,867 shares of the company’s stock, valued at $2,030,141.88. This trade represents a 10.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, COO Graham D. Reeve sold 662 shares of the business’s stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $78.86, for a total transaction of $52,205.32. Following the completion of the transaction, the chief operating officer directly owned 30,078 shares of the company’s stock, valued at approximately $2,371,951.08. This represents a 2.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 2.00% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On U.S. Physical Therapy

A number of large investors have recently added to or reduced their stakes in USPH. Allspring Global Investments Holdings LLC purchased a new stake in shares of U.S. Physical Therapy in the 3rd quarter worth about $845,000. JPMorgan Chase & Co. grew its holdings in shares of U.S. Physical Therapy by 106.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 109,837 shares of the company’s stock worth $9,331,000 after acquiring an additional 56,752 shares during the period. Bahl & Gaynor Inc. raised its position in shares of U.S. Physical Therapy by 47.6% in the 3rd quarter. Bahl & Gaynor Inc. now owns 474,688 shares of the company’s stock worth $40,325,000 after acquiring an additional 153,054 shares in the last quarter. William Blair Investment Management LLC purchased a new position in shares of U.S. Physical Therapy in the 3rd quarter valued at approximately $29,381,000. Finally, American Century Companies Inc. bought a new stake in shares of U.S. Physical Therapy during the third quarter valued at approximately $21,940,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.